Outbrain and Ligatus Join Forces to Form a Native Advertising Powerhouse
26.2.2019 14:00:00 EET | Business Wire | Press release
Outbrain, the world's leading discovery and native advertising platform on the open web, announced today that it has entered an agreement to acquire Ligatus, a fully owned subsidiary of Gruner + Jahr which is a Bertelsmann group company, in a stock deal.
Ligatus is a leading European based native advertising solution provider with headquarters in Cologne, Germany and offices in Germany, France, Spain, Italy, Belgium and Netherlands. Ligatus’ solutions bring advertisers and publishers together through high-impact, non-intrusive native ad placements, leveraging a mobile-first native ad solution for marketers to build awareness and engagement with the right audiences. Delivering more than 37 billion ad impressions per month, Ligatus provides tailored and contextual advertising alongside publisher content in a multi-device format while guaranteeing brand safety.
With the addition of the Ligatus premium publisher network, Outbrain will expand and strengthen its position in Europe with over 1,400 premium publishers, including STERN, RTL and Femme Actuelle.
“The acquisition of Ligatus is part of our market consolidation strategy and will allow us to expand our native offering to marketers and strengthen the relationship with our publisher partners,” said David Kostman, co-CEO of Outbrain. “By combining the sophisticated native advertising offering of Ligatus with Outbrain’s strong targeting technology and reach, the benefit for marketers, publishers and users will be a trustworthy feed of discovery that is powered with a strong underlying, non-interruptive advertising experience.”
“This transaction will grow Outbrain’s footprint in key new European markets and open a premium group of Gruner + Jahr and Bertelsmann publishers to our advertisers,” added Kostman.
“We are excited to join ranks with Outbrain in order to create a true native advertising powerhouse,” said Klaus Ludemann, CEO of Ligatus. “This combination will create a win-win for our publishers and advertising partners by leveraging the combined strengths of our teams,” added Ludemann.
“We are thrilled to become shareholders in Outbrain, the most premium discovery platform globally, and happy to announce that Arne Wolter, Chief Digital Officer of Gruner + Jahr, will join the board of directors of Outbrain,” said Julia Jaekel, CEO of Gruner + Jahr. “I believe this is a very positive development for premium publishers looking to engage loyal users, increase revenues and ensure a high quality user experience,” added Jaekel.
The acquisition is subject to certain regulatory and other approvals and is expected to close by the second quarter of 2019.
About Outbrain
Founded in 2006, Outbrain's mission is to create the most meaningful and trustworthy online discovery feeds connecting a person, channel and marketer. Outbrain’s native advertising technology powers the news, product & information feeds of the world’s most recognized publishers and channels including MSN, CNN, BBC, The Washington Post, The Guardian, Spiegel Online, El País and Sky News. Outbrain is headquartered in New York with offices in 15 cities worldwide. Learn more at outbrain.com or follow us on Twitter, LinkedIn or Instagram.
About Ligatus
Ligatus is the leading quality Native Advertising Solutions provider for Publishers and Marketers. The company offers Publishers a powerful native Supply Side Platform (SSP) along with consulting services, to generate the best revenues coming from high-quality brands and helps Marketers reach, engage and convert their target audience with advanced dynamic algorithms. Ligatus delivers more than 37 billion ad impressions per month in over 1,400 Premium partner sites in ten countries.
The company is headquartered in Cologne, Germany, and is a 100 percent subsidiary of Gruner + Jahr, which is fully owned by Bertelsmann.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190226005549/en/
Contact information
MEDIA:
Brian Gallagher
(646) 586-8990
bgallagher@outbrain.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Strengthens Digital Transformation Capabilities with Weexa30.4.2026 16:30:00 EEST | Press release
Andersen Consulting enters into a Collaboration Agreement with Weexa, a global provider of digital transformation, B2B integration, and supply chain digitalization solutions. Headquartered in France, Weexa delivers end-to-end services that help organizations streamline, secure, and scale their digital ecosystems. The firm specializes in B2B data-flow management and digitalization, enabling seamless communication between applications both within and across organizations through technologies such as EDI, APIs, and e-invoicing. Weexa also provides SAP integration and supply chain solutions spanning warehouse and transport management, alongside strategic consulting, project delivery, and third-party application maintenance. Serving organizations across the food, retail, wholesale, logistics, transportation, automotive, healthcare, and media sectors, Weexa supports global businesses in optimizing performance while meeting evolving regulatory and digital-compliance requirements. “Collaborati
SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 202430.4.2026 16:22:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (“SEC”). An electronic copy of the Annual Report can be accessed on SINOVAC’s investor relations website at https://www.sinovac.com/en-us/Investors and on the SEC’s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases. The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, et
Experian Announces Agent Trust to Power Trusted AI Driven Commerce30.4.2026 16:00:00 EEST | Press release
Experian today announced Experian Agent Trust™, a first-of-its-kind framework that establishes a secure, verifiable link between consumers and AI agents, bringing identity, and accountability to AI-driven transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430719198/en/ Experian Announces Agent Trust to Power Trusted AI Driven Commerce. As AI agents begin to search and transact autonomously, they introduce a fundamental challenge for businesses: how to trust an action when it is no longer driven by a human. Without a verified connection between humans and AI agents, autonomous commerce introduces new risks in fraud, misrepresentation, and unauthorized transactions. Experian Agent Trust addresses this challenge through a new “Know Your Agent” (KYA) framework, extending identity verification into the age of AI. The framework ensures that agent-initiated transactions are grounded in verified consumer identity. “Agen
Meet the AI-powered fan companion: TGR Haas F1 Team RaceMate powered by Infobip30.4.2026 16:00:00 EEST | Press release
Global AI-first cloud communications platform Infobip and TGR Haas F1 team are launching ‘TGR Haas F1 Team RaceMate powered by Infobip’, an AI-powered conversational fan companion on Apple Messages for Business and WhatsApp Business Platform. Always-on and always available, it delivers race intelligence for TGR Haas F1 Team: team race intelligence, grid positions, qualifying outcomes, sprint results, and full session schedules. The AI agent tracks drivers Ollie Bearman and Esteban Ocon with their individual championship standings and performance data in conversational format. The agent draws from a knowledge base covering driver biographies, team history, and circuit data, adapting to each user's knowledge level. Every interaction begins with a schedule check, ensuring fans always know what's happening right now. It proactively surfaces relevant information, suggests next actions, and maintains conversational flow to keep every interaction effortless and engaging. Delivered in short, s
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations30.4.2026 15:05:00 EEST | Press release
Merck, a leading global science and technology company, today announced the first patient was dosed in the Phase 3 program, ELOWEN-1 (NCT07332481) and ELOWEN-2 (NCT07355218), evaluating enpatoran in people living with lupus who experience active skin manifestations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260430733656/en/ David Weinreich, Global Head of R&D and Chief Medical Officer “People living with lupus continue to face significant challenges in achieving disease control and are very often affected by itchy, painful and stigmatized skin manifestations,” said David Weinreich, Global Head of R&D, Merck. “With enpatoran, we aim to target the underlying drivers of lupus and redefine how to approach the disease by understanding both visible skin manifestations and systemic activity.” Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor designed to modulate pathways central to lupus-related inflammatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom